US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about NYSE:NNVC

Recent news which mentions NYSE:NNVC

NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
Tags NYSE:NNVC
From News Direct
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Tickers AZN GSK PFE SNY
Tags NYSE:NNVC
From News Direct
NanoViricides progressing well with new Covid study
Tags NYSE:NNVC
From News Direct
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
Tags NYSE:NNVC
From News Direct
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
Tags NYSE:NNVC
From News Direct
NanoViricides using unique technology platform to fight against viruses
Tags NYSE:NNVC
From News Direct
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Tickers AZN GILD MRK MRNA
Tags NYSE:NNVC
From News Direct
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Tickers GILD MRK MRNA NVAX
Tags NYSE:NNVC
From News Direct
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
Tickers NNVC
Tags NYSE:NNVC
From News Direct
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Tickers NNVC
Tags NYSE:NNVC
From News Direct
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Tickers CTLT GILD SIGA
Tags NYSE:NNVC
From News Direct
Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution
Tickers SIGA
Tags NYSE:NNVC
From News Direct
What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors
Tickers NNVC
Tags NNVC NYSE:NNVC Today's Market
From InvestorPlace